These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 33615840)
1. CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache. Kopruszinski CM; Turnes JM; Swiokla J; Weinstein TJ; Schwedt TJ; Dodick DW; Anderson T; Navratilova E; Porreca F Cephalalgia; 2021 May; 41(6):749-759. PubMed ID: 33615840 [TBL] [Abstract][Full Text] [Related]
2. CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice. Navratilova E; Rau J; Oyarzo J; Tien J; Mackenzie K; Stratton J; Remeniuk B; Schwedt T; Anderson T; Dodick D; Porreca F Cephalalgia; 2019 Dec; 39(14):1762-1775. PubMed ID: 31550910 [TBL] [Abstract][Full Text] [Related]
3. Enhanced post-traumatic headache-like behaviors and diminished contribution of peripheral CGRP in female rats following a mild closed head injury. Bree D; Mackenzie K; Stratton J; Levy D Cephalalgia; 2020 Jun; 40(7):748-760. PubMed ID: 32077327 [TBL] [Abstract][Full Text] [Related]
4. Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache. Rudolph M; Kopruszinski C; Wu C; Navratilova E; Schwedt TJ; Dodick DW; Porreca F; Anderson T Cephalalgia; 2023 Nov; 43(11):3331024231217469. PubMed ID: 38016977 [TBL] [Abstract][Full Text] [Related]
5. Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache. Navratilova E; Oyarzo J; Anderson T; Broide RS; Subramaniam SR; Vazquez-Cintron EJ; Brin MF; Schwedt TJ; Dodick DW; Porreca F Cephalalgia; 2022 Oct; 42(11-12):1194-1206. PubMed ID: 35546268 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of 2-AG hydrolysis alleviates posttraumatic headache attributed to mild traumatic brain injury. Wen J; Tanaka M; Zhang Y J Headache Pain; 2024 Jul; 25(1):115. PubMed ID: 39014318 [TBL] [Abstract][Full Text] [Related]
7. Increased severity of closed head injury or repetitive subconcussive head impacts enhances post-traumatic headache-like behaviors in a rat model. Bree D; Stratton J; Levy D Cephalalgia; 2020 Oct; 40(11):1224-1239. PubMed ID: 32600065 [TBL] [Abstract][Full Text] [Related]
8. Effect of Voluntary Exercise on Endogenous Pain Control Systems and Post-traumatic Headache in Mice. Bharadwaj VN; Sahbaie P; Shi X; Irvine KA; Yeomans DC; Clark JD J Pain; 2023 Oct; 24(10):1859-1874. PubMed ID: 37271350 [TBL] [Abstract][Full Text] [Related]
9. Development of CGRP-dependent pain and headache related behaviours in a rat model of concussion: Implications for mechanisms of post-traumatic headache. Bree D; Levy D Cephalalgia; 2018 Feb; 38(2):246-258. PubMed ID: 27899434 [TBL] [Abstract][Full Text] [Related]
10. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine. Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305 [TBL] [Abstract][Full Text] [Related]
11. The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target. Moye LS; Novack ML; Tipton AF; Krishnan H; Pandey SC; Pradhan AA Cephalalgia; 2019 Jan; 39(1):77-90. PubMed ID: 29771142 [TBL] [Abstract][Full Text] [Related]
13. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain. Kopruszinski CM; Navratilova E; Swiokla J; Dodick DW; Chessell IP; Porreca F Cephalalgia; 2021 Mar; 41(3):305-317. PubMed ID: 32985222 [TBL] [Abstract][Full Text] [Related]
14. Loss of diffuse noxious inhibitory control after traumatic brain injury in rats: A chronic issue. Irvine KA; Sahbaie P; Ferguson AR; Clark JD Exp Neurol; 2020 Nov; 333():113428. PubMed ID: 32745472 [TBL] [Abstract][Full Text] [Related]
15. Kappa opioid signaling in the right central amygdala causes hind paw specific loss of diffuse noxious inhibitory controls in experimental neuropathic pain. Phelps CE; Navratilova E; Dickenson AH; Porreca F; Bannister K Pain; 2019 Jul; 160(7):1614-1621. PubMed ID: 30870321 [TBL] [Abstract][Full Text] [Related]
16. Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain. Yoneda S; Kasai E; Matsuo M; Tamano R; Sakurai Y; Asaki T; Fujita M Neurosci Lett; 2020 Jun; 729():134990. PubMed ID: 32315711 [TBL] [Abstract][Full Text] [Related]
17. Mild Traumatic Brain Injury-Induced Augmented Postsurgical Pain Is Driven by Central Serotonergic Pain-Facilitatory Signaling. Chen Q; Sahbaie P; Irvine KA; Clark JD Anesth Analg; 2024 Apr; 138(4):866-877. PubMed ID: 37083595 [TBL] [Abstract][Full Text] [Related]
18. The role of deficient pain modulatory systems in the development of persistent post-traumatic headaches following mild traumatic brain injury: an exploratory longitudinal study. Naugle KM; Carey C; Evans E; Saxe J; Overman R; White FA J Headache Pain; 2020 Dec; 21(1):138. PubMed ID: 33272206 [TBL] [Abstract][Full Text] [Related]
19. Impaired diffuse noxious inhibitory controls in specific alternation of rhythm in temperature-stressed rats. Itomi Y; Tsukimi Y; Kawamura T Eur J Pharmacol; 2016 Aug; 784():61-8. PubMed ID: 27178898 [TBL] [Abstract][Full Text] [Related]
20. Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury. Elliott MB; Oshinsky ML; Amenta PS; Awe OO; Jallo JI Headache; 2012 Jun; 52(6):966-84. PubMed ID: 22568499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]